tradingkey.logo

Myomo Inc

MYO
0.863USD
+0.022+2.67%
終値 11/05, 16:00ET15分遅れの株価
32.60M時価総額
損失額直近12ヶ月PER

Myomo Inc

0.863
+0.022+2.67%

詳細情報 Myomo Inc 企業名

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.

Myomo Incの企業情報

企業コードMYO
会社名Myomo Inc
上場日Jun 12, 2017
最高経営責任者「CEO」Mr. Paul R. Gudonis
従業員数184
証券種類Ordinary Share
決算期末Jun 12
本社所在地137 Portland Street
都市BOSTON
証券取引所NYSE American Consolidated
United States of America
郵便番号02114
電話番号16179969058
ウェブサイトhttps://myomo.com/
企業コードMYO
上場日Jun 12, 2017
最高経営責任者「CEO」Mr. Paul R. Gudonis

Myomo Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
事業別USD
会社名
収益
比率
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%

株主

更新時刻: Sat, Nov 1
更新時刻: Sat, Nov 1
株主統計
種類
株主統計
株主統計
比率
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
他の
67.55%
株主統計
株主統計
比率
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
他の
67.55%
種類
株主統計
比率
Hedge Fund
22.96%
Investment Advisor
22.00%
Investment Advisor/Hedge Fund
10.68%
Individual Investor
7.42%
Research Firm
2.77%
Venture Capital
0.16%
Pension Fund
0.16%
Bank and Trust
0.09%
他の
33.75%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
153
22.25M
58.86%
-1.76M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Rosalind Advisors, Inc.
3.60M
9.51%
+892.13K
+33.00%
Jun 30, 2025
Herr Investment Group LLC
2.85M
7.53%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.47%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
4%
+1.40M
+1213.08%
Jun 30, 2025
The Vanguard Group, Inc.
1.49M
3.94%
+226.35K
+17.94%
Jun 30, 2025
Gudonis (Paul R)
1.25M
3.3%
-10.00K
-0.79%
Sep 09, 2025
Journey Advisory Group, LLC
875.84K
2.32%
-248.95K
-22.13%
Jun 30, 2025
Worth Venture Partners, LLC
875.76K
2.32%
-312.69K
-26.31%
Jun 30, 2025
Soleus Capital Management, L.P.
704.27K
1.86%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
669.28K
1.77%
+412.63K
+160.78%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
比率0.01%
ProShares Hedge Replication ETF
比率0%
iShares Russell 2000 ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
Global X Russell 2000 ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares UltraPro Russell2000
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI